Scholarly Works

Fluvoxamine for the treatment of COVID-19 –...

Journal article

Fluvoxamine for the treatment of COVID-19 – Author's reply

Authors

Reis G; Mills E

Journal

The Lancet Global Health, Vol. 10, No. 3,

Publisher

Elsevier

Publication Date

March 1, 2022

DOI

10.1016/s2214-109x(21)00588-x

ISSN

2572-116X

Associated Experts

Edward Joseph Mills

Professor (Part-Time), Health Research Methods, Evidence, and Impact

Gilmar Reis

Associate Professor (Part-Time), Health Research Methods, Evidence, and Impact

Labels

Fields of Research (FoR)

4202 Epidemiology 4203 Health services and systems 4206 Public health 42 Health Sciences

Medical Subject Headings (MeSH)

Fluvoxamine Humans SARS-CoV-2 COVID-19 Drug Treatment

View published work (Non-McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback